1. Home
  2. ONC vs KDP Comparison

ONC vs KDP Comparison

Compare ONC & KDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • KDP
  • Stock Information
  • Founded
  • ONC 2010
  • KDP 1981
  • Country
  • ONC Switzerland
  • KDP United States
  • Employees
  • ONC N/A
  • KDP N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • KDP Beverages (Production/Distribution)
  • Sector
  • ONC Health Care
  • KDP Consumer Staples
  • Exchange
  • ONC Nasdaq
  • KDP Nasdaq
  • Market Cap
  • ONC 37.3B
  • KDP 39.5B
  • IPO Year
  • ONC N/A
  • KDP 1993
  • Fundamental
  • Price
  • ONC $342.50
  • KDP $25.35
  • Analyst Decision
  • ONC Strong Buy
  • KDP Buy
  • Analyst Count
  • ONC 10
  • KDP 16
  • Target Price
  • ONC $340.70
  • KDP $35.38
  • AVG Volume (30 Days)
  • ONC 297.4K
  • KDP 19.8M
  • Earning Date
  • ONC 11-11-2025
  • KDP 10-23-2025
  • Dividend Yield
  • ONC N/A
  • KDP 3.56%
  • EPS Growth
  • ONC N/A
  • KDP N/A
  • EPS
  • ONC N/A
  • KDP 1.13
  • Revenue
  • ONC $4,562,002,000.00
  • KDP $15,759,000,000.00
  • Revenue This Year
  • ONC $896.81
  • KDP $6.92
  • Revenue Next Year
  • ONC N/A
  • KDP $4.17
  • P/E Ratio
  • ONC N/A
  • KDP $22.90
  • Revenue Growth
  • ONC 47.33
  • KDP 4.63
  • 52 Week Low
  • ONC $170.99
  • KDP $25.27
  • 52 Week High
  • ONC $355.30
  • KDP $37.27
  • Technical
  • Relative Strength Index (RSI)
  • ONC 57.00
  • KDP 27.53
  • Support Level
  • ONC $334.53
  • KDP $25.27
  • Resistance Level
  • ONC $355.30
  • KDP $25.99
  • Average True Range (ATR)
  • ONC 7.30
  • KDP 0.46
  • MACD
  • ONC 0.00
  • KDP 0.14
  • Stochastic Oscillator
  • ONC 61.75
  • KDP 5.02

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About KDP Keurig Dr Pepper Inc.

Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.

Share on Social Networks: